Identifying genetic factors affecting child language development in Taiwan
Genetic Biomarkers of Child Language Development in Taiwan: an Identification and Validation Study
This study looks at how certain genes might affect language development in children aged 2 to 18 in Taiwan, especially those with language disorders, to better understand their needs.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 300 (estimated) |
| Ages | 2 Years to 8 Years |
| Sex | All |
| Sponsor | Chang Gung Memorial Hospital Academic / other |
| Locations | 1 site (Taoyuan) |
| Trial ID | NCT05504564 on ClinicalTrials.gov |
What this trial studies
This observational study explores the relationship between genetic biomarkers and language development in children aged 2 to 18 years in Taiwan. It aims to identify and validate genes associated with language disorders by examining the interaction between genetic factors and environmental influences. The study does not involve any interventions, focusing instead on the collection and analysis of genetic data to understand its impact on language development. Participants will include children with language disorders as well as their parents if genetic abnormalities are identified.
Who should consider this trial
Good fit: Ideal candidates for this study are children aged 2 to 18 years, particularly those with language disorders.
Not a fit: Patients with central nervous system diseases, neuromuscular disorders, congenital abnormalities, genetic diseases, dysesthesia, or hearing impairments may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved understanding and early identification of language disorders in children, potentially guiding interventions.
How similar studies have performed: While studies on genetic influences on language development exist, this specific approach focusing on Taiwanese children is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 2-18 y/o * Agree to sign informed consent Exclusion Criteria: * Central nervous system disease * Neuromuscular Disorders * Congenital Abnormality * Genetic Disease * Dysesthesia * Hearing Impairment Inclusion Criteria of Child with language disorder: * Patients with Language Disorder * Age 2-18 y/o * Agree to sign informed consent * Exclusion Criteria of Child with language disorder: * Hearing Impairment Inclusion Criteria of Adult: * His or her child participated in this study, and gene abnormality was found.
Where this trial is running
Taoyuan
- Chang Gung Memoria Hospital — Taoyuan, Taiwan (Recruiting)
Study contacts
- Study coordinator: Chia-Ling Chen, MD, PhD
- Email: clingchen@gmail.com
- Phone: +883-3-3281200
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.